What drug class is Mephyton?

Phytonadione is in a class of medications called vitamins. It works by providing vitamin K that is needed for blood to clot normally in the body.

What is Mephyton used for?

Mephyton (phytonadione) is a man-made form of vitamin K used to treat vitamin K deficiency and to treat certain bleeding or blood clotting problems. Mephyton usually has very few side effects.

How is AquaMEPHYTON given to newborns?

The American Academy of Pediatrics recommends that vitamin K1 be given to the newborn. A single intramuscular dose of AquaMEPHYTON 0.5 to 1 mg within one hour of birth is recommended. Empiric administration of vitamin K1 should not replace proper laboratory evaluation of the coagulation mechanism.

What is AquaMEPHYTON used for in newborns?

AquaMEPHYTON is indicated for prophylaxis and treatment of vitamin K-deficiency bleeding in neonates.

How many milligrams of mephyton should I take?

To correct excessively prolonged prothrombin times caused by oral anticoagulant therapy – 2.5 to 10 mg or up to 25 mg initially is recommended. In rare instances 50 mg may be required. Frequency and amount of subsequent doses should be determined by prothrombin time response or clinical condition.

How often should you take mephyton for cholestasis?

Initially, 2 to 25 mg PO as single dose, repeated as necessary, depending on patient response and the severity of the deficiency. The dosage may be increased up to 50 mg, but this is not usually required. 2.5 to 5 mg PO, given 2 to 7 times/week may be required to prevent deficiency; up to 10 mg daily may be needed in children with cholestasis.

What’s the best dosage for aquamephyton for bleeding?

Recommended Dosage For Prophylaxis And Therapy Of Vitamin K Deficiency Bleeding In Neonates. Prophylaxis Of Vitamin K-Deficiency Bleeding In Neonates. The recommended dosage of AquaMEPHYTON is 0.5 mg to 1 mg within one hour of birth for a single dose.

How many mg of phytonadione should I take?

Initially, 2 to 25 mg IM/subcutaneously, repeated as necessary, depending on patient response and the severity of the deficiency. The dosage may be increased up to 50 mg, but this is not usually required. Initially, 5 to 10 mg IM/subcutaneously, repeated as necessary, depending on patient response and the severity of the deficiency.